Cargando…
Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library
There is a desperate need for safe and effective vaccines, therapies, and diagnostics for SARS– coronavirus 2 (CoV-2), the development of which will be aided by the discovery of potent and selective antibodies against relevant viral epitopes. Human phage display technology has revolutionized the pro...
Autores principales: | Parray, Hilal Ahmad, Chiranjivi, Adarsh Kumar, Asthana, Shailendra, Yadav, Naveen, Shrivastava, Tripti, Mani, Shailendra, Sharma, Chandresh, Vishwakarma, Preeti, Das, Supratik, Pindari, Kamal, Sinha, Subrata, Samal, Sweety, Ahmed, Shubbir, Kumar, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476711/ https://www.ncbi.nlm.nih.gov/pubmed/32727845 http://dx.doi.org/10.1074/jbc.AC120.014918 |
Ejemplares similares
-
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro
por: Vishwakarma, Preeti, et al.
Publicado: (2021) -
Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives
por: Parray, Hilal Ahmed, et al.
Publicado: (2020) -
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus
por: Murugavelu, Praveenkumar, et al.
Publicado: (2021) -
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41
por: Perween, Reshma, et al.
Publicado: (2021) -
Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection
por: Kumar, Rajesh, et al.
Publicado: (2020)